Billing the pharmaceutical market grows 12% in the first quarter of 2015

The billing of the pharmaceutical market grew 12% in the first quarter of this year, to $ 10.7 billion, compared with the same period in 2014. April 2014 and March 2015, the sales in pharmacies grew 11.5% as compared to the same previous interval to r $ 43.1 billion, according to IMS Health data compiled by Interfarma-research-based pharmaceutical industry association.
"Even at this difficult time for the economy, the pharmaceutical industry is showing growth practically stable and far above other sectors", says the Chief Executive of Interfarma, Antonio Britto, explaining that because the medicines are products of first necessity. "However, we can't rule out the possibility of a negative impact on the course of the year," says, by way of note.
In number of doses sold, the increase was of 9.8%, to 32.5 billion in the first quarter of 2015, and of 8.5% over the last 12 months, with 132 billion doses sold. Generics have remained stable with participation of 13%. The similar category already advanced 1 percentage point from 2014 to 2015, reaching 48%. The reference medicines fell one point to 39 percent, the survey of mobile months doses until March.